Azerbaijan vs Sur: Estimated antiretroviral therapy coverage among children
Azerbaijan
87
in 2025
Sur
20
in 2024
Azerbaijan rank
3rd
Sur rank
1st
Estimated antiretroviral therapy coverage among children over time
- Azerbaijan
- Sur
How they compare
Azerbaijan currently reports 87 against 20 in Sur, a difference of 67.
That makes Azerbaijan's figure about 4.3 times Sur's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Sur ahead.
Azerbaijan ranks 3rd and Sur ranks 1st of 89 countries.
Across the 3 decades both report, Azerbaijan averaged higher in 1 and Sur in 2.
Head to head by decade
| Decade | Azerbaijan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2 | 17.3 | 17.1 | Sur |
| 2010s | 34.2 | 40.9 | 6.7 | Sur |
| 2020s | 69.8 | 26.6 | 43.2 | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Azerbaijan or Sur?
- Azerbaijan, at 87 against 20 in Sur as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Azerbaijan and Sur?
- 67, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Sur?
- 25 years are reported by both, from 2000 to 2024.
- How do Azerbaijan and Sur rank globally for estimated antiretroviral therapy coverage among children?
- Azerbaijan ranks 3rd and Sur ranks 1st of 89 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.